Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection

Macrophages are resistant to constitutive apoptosis, but infectious stimuli can induce either microbial or host‐mediated macrophage apoptosis. Phagocytosis and killing of opsonized pneumococci by macrophages are potent stimuli for host‐mediated apoptosis, but the link between pneumococcal killing and apoptosis induction remains undefined. We now show phagocytosis of pneumococci by differentiated human monocyte‐derived macrophages (MDM) results in up‐regulation of inducible nitric oxide synthase (iNOS) and increased production of NO and reactive nitrogen species. NO accumulation in macrophages initiates an apoptotic program that involves NO‐dependent mitochondrial membrane permeabilization, Mcl‐1 down‐ regulation, and caspase activation and results in nuclear condensation and fragmentation. An inhibitor of mitochondrial permeability transition, bongkrekic acid, decreases pneumococcal‐ associated macrophage apoptosis. Conversely, inhibition of NO production using iNOS inhibitors decreases bacterial killing and shifts the cell death program from apoptosis to necrosis. Pneumolysin contributes to both NO production and apoptosis induction. After initial microbial killing, NO accumulation switches the macrophage phenotype from an activated cell to a cell susceptible to apoptosis. These results illustrate important roles for NO in the integration of host defense and regulation of inflammation in human macrophages.

[1]  C. Nathan,et al.  The Proteasome of Mycobacterium tuberculosis Is Required for Resistance to Nitric Oxide , 2003, Science.

[2]  A. Álvarez,et al.  Sustained Nitric Oxide Delivery Delays Nitric Oxide-Dependent Apoptosis in Macrophages: Contribution to the Physiological Function of Activated Macrophages 1 , 2003, The Journal of Immunology.

[3]  C. Szabó,et al.  Mitochondrial nitric oxide synthase is not eNOS, nNOS or iNOS. , 2003, Free radical biology & medicine.

[4]  P. Ince,et al.  Alveolar Macrophage Apoptosis Contributes to Pneumococcal Clearance in a Resolving Model of Pulmonary Infection 1 , 2003, The Journal of Immunology.

[5]  T. Mitchell,et al.  Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. , 2003, The Journal of infectious diseases.

[6]  G. Ulett,et al.  β-Hemolysin–Independent Induction of Apoptosis of Macrophages Infected with Serotype III Group B Streptococcus , 2003 .

[7]  S. Kaufmann,et al.  Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis , 2003, Nature Medicine.

[8]  N. Reiner,et al.  Survival of Mycobacterium tuberculosis in Host Macrophages Involves Resistance to Apoptosis Dependent upon Induction of Antiapoptotic Bcl-2 Family Member Mcl-11 , 2003, The Journal of Immunology.

[9]  N. McElvaney,et al.  Cytosolic pH and the inflammatory microenvironment modulate cell death in human neutrophils after phagocytosis. , 2002, Blood.

[10]  R. Read,et al.  Flavohemoglobin Hmp Protects Salmonella enterica Serovar Typhimurium from Nitric Oxide-Related Killing by Human Macrophages , 2002, Infection and Immunity.

[11]  B. Brüne,et al.  Nitric oxide prevents oxidised LDL-induced p53 accumulation, cytochrome c translocation, and apoptosis in macrophages via guanylate cyclase stimulation. , 2002, Atherosclerosis.

[12]  N. Calonghi,et al.  Mitochondrial nitric oxide localization in H9c2 cells revealed by confocal microscopy. , 2002, Biochemical and biophysical research communications.

[13]  Y. Urano,et al.  Orthogonality of Calcium Concentration and Ability of 4,5-Diaminofluorescein to Detect NO* , 2002, The Journal of Biological Chemistry.

[14]  S. Deventer,et al.  The Role of Interferon-γ in Murine Pneumococcal Pneumonia , 2002 .

[15]  Adrian Ozinsky,et al.  Phagocytosis of microbes: complexity in action. , 2002, Annual review of immunology.

[16]  J. Cleveland,et al.  Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. , 2002, The Journal of clinical investigation.

[17]  T. van der Poll,et al.  The role of interferon-gamma in murine pneumococcal pneumonia. , 2002, The Journal of infectious diseases.

[18]  T. Gingeras,et al.  Reprogramming of the Macrophage Transcriptome in Response to Interferon-γ and Mycobacterium tuberculosis , 2001, The Journal of experimental medicine.

[19]  D. Holden,et al.  Macrophage Nitric Oxide Synthase Associates with Cortical Actin but Is Not Recruited to Phagosomes , 2001, Infection and Immunity.

[20]  R. Read,et al.  Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. , 2001, The Journal of infectious diseases.

[21]  H. Perlman,et al.  Constitutively Activated Akt-1 Is Vital for the Survival of Human Monocyte-Differentiated Macrophages , 2001, The Journal of experimental medicine.

[22]  Melissa A. Miller,et al.  Oxidative Responses of Human and Murine Macrophages During Phagocytosis of Leishmania chagasi1 , 2001, The Journal of Immunology.

[23]  J. Chatton,et al.  Photoactivation and calcium sensitivity of the fluorescent NO indicator 4,5‐diaminofluorescein (DAF‐2): implications for cellular NO imaging , 2001, FEBS letters.

[24]  T. Gingeras,et al.  Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. , 2001, The Journal of experimental medicine.

[25]  S Moncada,et al.  The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Kroemer,et al.  Bid acts on the permeability transition pore complex to induce apoptosis , 2000, Oncogene.

[27]  S. Gillespie,et al.  Pathogenesis of pneumococcal infection. , 2000, Journal of medical microbiology.

[28]  C. Nathan,et al.  Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  F. Fang,et al.  Antimicrobial Actions of the Nadph Phagocyte Oxidase and Inducible Nitric Oxide Synthase in Experimental Salmonellosis. I. Effects on Microbial Killing by Activated Peritoneal Macrophages in Vitro , 2000, The Journal of experimental medicine.

[30]  G. Dougan,et al.  Antimicrobial Actions of the Nadph Phagocyte Oxidase and Inducible Nitric Oxide Synthase in Experimental Salmonellosis. II. Effects on Microbial Proliferation and Host Survival in Vivo , 2000, The Journal of experimental medicine.

[31]  Y. Kwaik,et al.  The modulation of host cell apoptosis by intracellular bacterial pathogens. , 2000, Trends in microbiology.

[32]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[33]  M. Grisham,et al.  Reactive Nitrogen and Oxygen Species Attenuate Interleukin- 8-induced Neutrophil Chemotactic Activity in Vitro * , 2000, The Journal of Biological Chemistry.

[34]  R. Read,et al.  Intracellular Trafficking and Killing ofStreptococcus pneumoniae by Human Alveolar Macrophages Are Influenced by Opsonins , 2000, Infection and Immunity.

[35]  A. Álvarez,et al.  Nitric oxide induces tyrosine nitration and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  J. Stamler,et al.  NO: an inhibitor of cell death , 1999, Cell Death and Differentiation.

[37]  B. Brüne,et al.  Nitric oxide (NO): an effector of apoptosis , 1999, Cell Death and Differentiation.

[38]  M. Bergeron,et al.  Immunomodulation of Pneumococcal Pulmonary Infection withNG-Monomethyl-l-Arginine , 1999, Antimicrobial Agents and Chemotherapy.

[39]  J. Shenep,et al.  Pneumolysin, a Protein Toxin of Streptococcus pneumoniae, Induces Nitric Oxide Production from Macrophages , 1999, Infection and Immunity.

[40]  H. Kolb,et al.  Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? , 1998, Immunology today.

[41]  J. Shenep,et al.  Pneumococci stimulate the production of the inducible nitric oxide synthase and nitric oxide by murine macrophages. , 1998, The Journal of infectious diseases.

[42]  J C Reed,et al.  Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. , 1998, Science.

[43]  H. Macdonald,et al.  Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. , 1998, Journal of immunology.

[44]  S. Kawahara,et al.  Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. , 1998, Analytical chemistry.

[45]  P. Kubes,et al.  Inducible nitric oxide synthase‐deficient mice have enhanced leukocyte–endothelium interactions in endotoxemia , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  N. Kendrick,et al.  ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. , 1997, Immunity.

[47]  P. Sansonetti,et al.  Perspectives series: host/pathogen interactions. Apoptosis in bacterial pathogenesis. , 1997, The Journal of clinical investigation.

[48]  G. Puzo,et al.  Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. , 1997, Journal of immunology.

[49]  S. Thom,et al.  Nitric oxide inhibits neutrophil β2 integrin function by inhibiting membrane‐associated cyclic GMP synthesis , 1997, Journal of cellular physiology.

[50]  F. Fang Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. , 1997, The Journal of clinical investigation.

[51]  J. Mudgett,et al.  Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[53]  Richard Graham Knowles,et al.  1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo* , 1997, The Journal of Biological Chemistry.

[54]  J. Keane,et al.  Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis , 1997, Infection and immunity.

[55]  N. Boéchat,et al.  Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis , 1996, The Journal of experimental medicine.

[56]  B. Chernyak,et al.  Modulation of the Mitochondrial Permeability Transition Pore by Pyridine Nucleotides and Dithiol Oxidation at Two Separate Sites (*) , 1996, The Journal of Biological Chemistry.

[57]  C. Nathan,et al.  Natural resistance and nitric oxide , 1995, Cell.

[58]  J. Weinberg,et al.  Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. , 1995, Blood.

[59]  E. Tuomanen,et al.  Pathogenesis of pneumococcal infection. , 1995, The New England journal of medicine.

[60]  Y. Vodovotz,et al.  Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. , 1995, Journal of immunology.

[61]  G. Kaplan,et al.  Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin , 1994, The Journal of experimental medicine.

[62]  M. Ernst,et al.  Nitric oxide synthase: MRNA expression of different isoforms in human monocytes/macrophages , 1994, European journal of immunology.

[63]  B. Vargaftig,et al.  Selective Mycobacterium avium–induced production of nitric oxide by human monocyte‐derived macrophages , 1994, Journal of leukocyte biology.

[64]  H. Reynolds,et al.  Macrophages and polymorphonuclear neutrophils in lung defense and injury. , 1990, The American review of respiratory disease.